Efficacy and Safety of DTG/3TC in Pregnancy

ViiV Healthcare welcomes investigator-sponsored research that advances understanding of the efficacy and safety of DTG/3TC in pregnancy. Research of interest may include real-world effectiveness, safety and tolerability, patient and provider experience, and health-related quality of life. We encourage innovative approaches and studies across diverse populations that can expand real-world knowledge and inform clinical practice.

ViiV ISR Area Of Interest Overview

Drug/Product Alignment

ViiV Products in Scope:	Dolutegravir
Treatment Type:	Treatment
Specify the Treatment Type:

Area of Interest/DataGap Description

Core Focus Area:	Efficacy/Effectiveness, Safety and Tolerability
Example Research Question(s):	• What is the real-world effectiveness and safety of DTG/3TC in pregnant individuals?

Desirable Study Parameters

Populations of Interest:	Pregnant Individuals, Treatment Naïve
Geographical Regions:	Global

Version 20250909-disp

- Back to Top -

Efficacy and Safety of DTG/3TC in Pregnancy

ViiV ISR Area Of Interest Overview

Pure Substance Request

Investigator Sponsored Study (ISS)

Collaborative Study